Montreal, Canada
LinguAI, founded in 2019, is a forward-thinking startup located in Canada that is leveraging AI and Machine Learning to revolutionize the detection of speech-language disorders in children. By offering a customized speech recognition solution, it analyzes speech samples with precision, providing results 15% more accurate than traditional methods and in just 20% of the time.
Poised at the intersection of AI, Big Data, and Education, LinguAI promises significant value to both parents and clinicians seeking rapid diagnostic insights. Their innovative approach not only enhances accuracy but also optimizes the efficiency of speech analysis.
Securing a Pre Seed Round investment on 24 September 2020 with backing from renowned players like NEXT Canada and Next AI, LinguAI is well-positioned for growth in the rapidly evolving tech-enabled healthcare space, making it a compelling prospect for strategic investors looking to support AI-driven healthcare solutions.
